Yaupon Nets $4 Million

Yaupon Therapeutics, a Radnor, Pa.-based drug company focused on lymphoma, addiction and neuropathic pain, has raised $4 million in Series B funding. Osage Ventures led the deal, and was joined by Ben Franklin Technology Partners, TDH Capital and return backer BioAdvance Greenhouse Fund. www.yaupontherapeutics.com